FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

510(k) Guidances for 2 Ultrasound-type Devices Published

FDA publishes two 510(k) guidances on ultrasound and related types of devices.

latest-news-card-1
Human Drugs

Intarcia Agrees to Advisory Committee to Resolve Review Dispute

Intarcia Therapeutics accepts an FDA proposal to allow an advisory committee to review and address a 2021 CDER decision not to approve the companys Ty...

latest-news-card-1
Federal Register

Lagevrio Misses Endpoint in Covid-19 Study

Merck says a study of its Covid-19 drug Lagevrio (molnupiravir) did not meet the primary endpoint a statistically significant risk reduction in those...

latest-news-card-1
Human Drugs

Regulatory Agenda Eyes DTC Ads and Med Guides

HHS publishes its semiannual regulatory agenda that outlines numerous FDA rulemaking activities under development, including a final rule on DTC Rx dr...

latest-news-card-1
Human Drugs

FDA OKs Chiesis Lamzede for Alpha-Mannosidosis

FDA approves Chiesis Lamzede to treat some manifestations of alpha-mannosidosis in adults and children.

latest-news-card-1
Federal Register

FDA Withdraws Miles Laboratories ANDA

Federal Register notice: FDA withdraws a Miles Laboratories ANDA for alcohol and dextrose injection, 5 mL/100 mL because the agency has scientific dat...

Human Drugs

Product-Specific Guidance Meetings

FDA publishes a draft guidance with information on requesting and conducting product-specific guidance meetings between FDA and ANDA applicants.

latest-news-card-1

Califf Sees Misinformation as Cause of Preventable Deaths

FDA commissioner Robert Califf announces a project to explore ways the agency can respond to and counter misleading health information in a variety of...

Medical Devices

Zephyrus Safety Syringe Cleared

FDA clears a Zephyrus Innovations 510(k) for its Aerojec 3ml safety syringe.

Human Drugs

FDA OKs Apellis Syfovre for Geographic Atrophy

FDA approves Apellis Pharmaceuticals Syfovre to treat geographic atrophy secondary to age-related macular degeneration.